BRCA2 and breast carcinoma: Moreover, the BIC (Breast Cancer Information Core, https://research.nhgri.nih.gov/bic/) database presently annotates the variant as of unknown clinical importance, pending classification, while the BRCA ShareTM (UMD‐BRCA2 mutations database) (https://www.umd.be/BRCA2/) classifies it as likely benign.